I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A phase II trial of a personalized dose-intense administrat..:
Sundquist, Fredrik
;
Georgantzi, Kleopatra
;
Jarvis, Kirsten Brunsvig
...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2022.836230. , 2022
Link:
https://repository.vu.lt/VU:ELABAPDB127732055&prefLang..
RT Journal T1
A phase II trial of a personalized dose-intense administration schedule of 177Lutetium-DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma–LuDO-N
UL https://suche.suub.uni-bremen.de/peid=base-ftvilniusuniv:oai:vu.lt:elaba:127732055&Exemplar=1&LAN=DE A1 Sundquist, Fredrik A1 Georgantzi, Kleopatra A1 Jarvis, Kirsten Brunsvig A1 Brok, Jesper A1 Koskenvuo, Minna A1 Rascon, Jelena A1 van Noesel, Max A1 Grybäck, Per A1 Nilsson, Joachim A1 Braat, Arthur A1 Sundin, Mikael A1 Wessman, Sandra A1 Herold, Nikolas A1 Hjorth, Lars A1 Kogner, Per A1 Granberg, Dan A1 Gaze, Mark A1 Stenman, Jakob YR 2022 K1 177Lu-DOTATATE K1 high-risk K1 neuroblastoma K1 PRRT K1 radiopharmaceutical K1 refractory K1 relapse K1 therapy JF info:eu-repo/semantics/altIdentifier/doi/10.3389/fped.2022.836230 LK http://dx.doi.org/https://repository.vu.lt/VU:ELABAPDB127732055&prefLang=en_US DO https://repository.vu.lt/VU:ELABAPDB127732055&prefLang=en_US SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)